Liver Transplantation in Intrahepatic Cholangiocarcinoma
Part of paid clinical trials in Newark, New Jersey.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT06140134
- Status
- Recruiting
Conditions
- Cholangiocarcinoma, Intrahepatic
- Intrahepatic Cholangiocarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Liver Transplant — PROCEDUREWhole liver allotransplantation will be performed for patients on the liver transplant waiting list
Study Details
The aim of the current study is to determine the potential efficacy of liver transplantation in the form of patients' overall survival (OS) after neoadjuvant systemic therapy in patients with biologically responsive locally advanced non-metastatic intrahepatic cholangiocarcinoma (iCCA) in comparison to patients historically treated with chemotherapy alone.
Key Dates
- Start date
- Dec 15, 2023
- Status verified
- Mar 2026
- Primary completion
- Nov 30, 2028
- Completion
- Nov 30, 2029
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: Intrahepatic cholangiocarcinoma listed for liver transplantListed patients enrolled with diagnosis of intrahepatic cholangiocarcinoma will be enrolled on an intent to treat basis with comparison between patients receiving transplant versus those who expire or are removed from the waitlist.
Primary Outcome Measure
5-year Overall Survival Rate (ORS) [ Time Frame: 5 years from the time of transplant or until death of patient, whichever came first ]
Central Contacts
- Melissa Lugardo973-972-8412
- Angenie Preval, PA
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rutgers New Jersey Medical School | Newark | New Jersey | 07103 | Keri E Lunsford, MD, PhD |
| University Hospital | Newark | New Jersey | 07103 | Keri E Lunsford, MD, PhD Keri E Lunsford, MD, PhD (PRINCIPAL_INVESTIGATOR) James V Guarrera, MD (SUB_INVESTIGATOR) Flavio Paterno, MD (SUB_INVESTIGATOR) Arpit Amin, MD (SUB_INVESTIGATOR) Grace S Lee-Riddle, MD (SUB_INVESTIGATOR) |
Find similar trials in Newark, NJ
Related Studies
- Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Bethesda, Maryland
- A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsPHASE1/PHASE2 · Recruiting · Alentis Therapeutics AG · Phoenix, Arizona
- Regional or Extend LymphAdenectomy During Resection of Intrahepatic CholangiocarcinomaRecruiting · Second Affiliated Hospital, School of Medicine, Zhejiang University · Baltimore, Maryland
- An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic CholangiocarcinomaPHASE2 · Recruiting · Virogin Biotech Canada Ltd · Phoenix, Arizona